Concepts (161)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Infant, Extremely Premature | 7 | 2025 | 113 | 2.540 |
Why?
|
| Xylitol | 2 | 2025 | 10 | 1.770 |
Why?
|
| Infant, Newborn, Diseases | 3 | 2023 | 177 | 1.690 |
Why?
|
| Premature Birth | 3 | 2025 | 428 | 1.680 |
Why?
|
| Zika Virus Infection | 5 | 2019 | 173 | 1.550 |
Why?
|
| Infant, Newborn | 27 | 2026 | 8635 | 1.290 |
Why?
|
| Child Development | 4 | 2025 | 266 | 1.290 |
Why?
|
| Global Health | 5 | 2025 | 626 | 1.200 |
Why?
|
| Developmental Disabilities | 2 | 2025 | 781 | 1.180 |
Why?
|
| Zika Virus | 4 | 2019 | 150 | 1.150 |
Why?
|
| Milk, Human | 4 | 2024 | 321 | 1.140 |
Why?
|
| Infant Health | 2 | 2019 | 17 | 1.130 |
Why?
|
| Chewing Gum | 2 | 2025 | 13 | 1.090 |
Why?
|
| Pregnancy Complications, Infectious | 4 | 2020 | 514 | 1.020 |
Why?
|
| Birth Weight | 2 | 2025 | 347 | 0.990 |
Why?
|
| Enterocolitis, Necrotizing | 4 | 2025 | 259 | 0.970 |
Why?
|
| Weight Loss | 4 | 2025 | 538 | 0.960 |
Why?
|
| Infant, Premature | 6 | 2026 | 872 | 0.870 |
Why?
|
| Microbiota | 3 | 2019 | 438 | 0.870 |
Why?
|
| Sweetening Agents | 1 | 2024 | 37 | 0.850 |
Why?
|
| Periodontal Diseases | 1 | 2024 | 31 | 0.850 |
Why?
|
| Patient Care Bundles | 1 | 2023 | 21 | 0.780 |
Why?
|
| Body Fluids | 1 | 2023 | 45 | 0.780 |
Why?
|
| Infant Nutritional Physiological Phenomena | 1 | 2024 | 175 | 0.760 |
Why?
|
| Weight Gain | 1 | 2025 | 393 | 0.750 |
Why?
|
| Bioethics | 1 | 2024 | 84 | 0.740 |
Why?
|
| Infectious Disease Transmission, Vertical | 4 | 2020 | 262 | 0.680 |
Why?
|
| Pregnancy | 12 | 2025 | 7512 | 0.660 |
Why?
|
| Perinatal Mortality | 1 | 2020 | 44 | 0.640 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2022 | 150 | 0.620 |
Why?
|
| Health Resources | 1 | 2021 | 131 | 0.600 |
Why?
|
| Mentoring | 1 | 2021 | 85 | 0.590 |
Why?
|
| Mentors | 1 | 2021 | 170 | 0.580 |
Why?
|
| Microcephaly | 4 | 2019 | 347 | 0.560 |
Why?
|
| Malawi | 3 | 2025 | 348 | 0.560 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2020 | 333 | 0.550 |
Why?
|
| Mothers | 1 | 2021 | 388 | 0.540 |
Why?
|
| Metagenome | 1 | 2019 | 138 | 0.540 |
Why?
|
| Metagenomics | 1 | 2019 | 116 | 0.540 |
Why?
|
| Pregnancy Complications | 1 | 2023 | 567 | 0.530 |
Why?
|
| Maternal Health | 1 | 2018 | 31 | 0.530 |
Why?
|
| Patient Discharge | 1 | 2021 | 514 | 0.510 |
Why?
|
| Gastrointestinal Microbiome | 2 | 2024 | 842 | 0.500 |
Why?
|
| Growth Disorders | 1 | 2018 | 181 | 0.500 |
Why?
|
| Eye Abnormalities | 1 | 2016 | 105 | 0.460 |
Why?
|
| Prenatal Care | 3 | 2024 | 345 | 0.450 |
Why?
|
| Gestational Age | 6 | 2026 | 1224 | 0.440 |
Why?
|
| Female | 22 | 2026 | 70963 | 0.430 |
Why?
|
| Humans | 32 | 2026 | 131163 | 0.430 |
Why?
|
| Granulomatous Disease, Chronic | 1 | 2014 | 68 | 0.420 |
Why?
|
| Fetal Diseases | 1 | 2018 | 440 | 0.410 |
Why?
|
| Lymphohistiocytosis, Hemophagocytic | 1 | 2014 | 160 | 0.370 |
Why?
|
| Congenital Abnormalities | 1 | 2016 | 330 | 0.370 |
Why?
|
| Intensive Care Units, Neonatal | 4 | 2026 | 361 | 0.360 |
Why?
|
| Internship and Residency | 1 | 2021 | 1223 | 0.320 |
Why?
|
| Prospective Studies | 4 | 2026 | 6459 | 0.250 |
Why?
|
| Quadriceps Muscle | 1 | 2026 | 16 | 0.240 |
Why?
|
| Health Facilities | 1 | 2025 | 66 | 0.220 |
Why?
|
| Male | 12 | 2026 | 64957 | 0.210 |
Why?
|
| Brain | 5 | 2024 | 3175 | 0.210 |
Why?
|
| Environmental Health | 1 | 2024 | 22 | 0.200 |
Why?
|
| Infant, Low Birth Weight | 1 | 2024 | 172 | 0.200 |
Why?
|
| Neurodevelopmental Disorders | 3 | 2025 | 629 | 0.200 |
Why?
|
| Erythrocyte Transfusion | 1 | 2025 | 146 | 0.200 |
Why?
|
| Parenteral Nutrition | 1 | 2025 | 219 | 0.200 |
Why?
|
| Social Justice | 1 | 2024 | 65 | 0.200 |
Why?
|
| Infant | 6 | 2025 | 13352 | 0.200 |
Why?
|
| Point-of-Care Systems | 1 | 2026 | 214 | 0.190 |
Why?
|
| Quality Indicators, Health Care | 1 | 2025 | 240 | 0.190 |
Why?
|
| Enteral Nutrition | 1 | 2025 | 290 | 0.190 |
Why?
|
| Quality of Health Care | 1 | 2025 | 413 | 0.180 |
Why?
|
| Cerebral Hemorrhage | 1 | 2023 | 158 | 0.180 |
Why?
|
| Spectroscopy, Near-Infrared | 1 | 2023 | 159 | 0.180 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 1267 | 0.160 |
Why?
|
| Maternal Mortality | 1 | 2020 | 78 | 0.160 |
Why?
|
| Child, Preschool | 3 | 2025 | 15110 | 0.160 |
Why?
|
| Infant, Very Low Birth Weight | 1 | 2021 | 176 | 0.150 |
Why?
|
| Muscle, Skeletal | 1 | 2026 | 981 | 0.150 |
Why?
|
| Breast Feeding | 1 | 2021 | 240 | 0.150 |
Why?
|
| Drug Utilization | 1 | 2020 | 164 | 0.150 |
Why?
|
| Brain Injuries | 1 | 2024 | 710 | 0.140 |
Why?
|
| Time Factors | 2 | 2025 | 6196 | 0.140 |
Why?
|
| Forecasting | 1 | 2019 | 351 | 0.130 |
Why?
|
| Perinatal Care | 1 | 2018 | 65 | 0.130 |
Why?
|
| Pregnancy Outcome | 1 | 2020 | 623 | 0.130 |
Why?
|
| Fellowships and Scholarships | 1 | 2020 | 327 | 0.120 |
Why?
|
| Americas | 1 | 2016 | 52 | 0.120 |
Why?
|
| Brazil | 1 | 2016 | 116 | 0.120 |
Why?
|
| Exanthema | 1 | 2017 | 74 | 0.120 |
Why?
|
| Immunoglobulin M | 1 | 2016 | 210 | 0.120 |
Why?
|
| United States | 2 | 2025 | 12072 | 0.120 |
Why?
|
| Fetus | 1 | 2019 | 568 | 0.120 |
Why?
|
| Probiotics | 1 | 2018 | 227 | 0.110 |
Why?
|
| NADPH Oxidase 2 | 1 | 2014 | 38 | 0.110 |
Why?
|
| Fungemia | 1 | 2014 | 22 | 0.110 |
Why?
|
| beta-Glucans | 1 | 2014 | 21 | 0.110 |
Why?
|
| Granulocytes | 1 | 2014 | 69 | 0.110 |
Why?
|
| Proteoglycans | 1 | 2014 | 77 | 0.110 |
Why?
|
| Fever of Unknown Origin | 1 | 2014 | 44 | 0.110 |
Why?
|
| Placenta | 1 | 2019 | 504 | 0.110 |
Why?
|
| Opportunistic Infections | 1 | 2014 | 69 | 0.100 |
Why?
|
| Immunization, Passive | 1 | 2014 | 120 | 0.100 |
Why?
|
| NADPH Oxidases | 1 | 2014 | 109 | 0.100 |
Why?
|
| Young Adult | 3 | 2024 | 10103 | 0.100 |
Why?
|
| Skin | 1 | 2017 | 545 | 0.100 |
Why?
|
| Pandemics | 1 | 2020 | 1118 | 0.100 |
Why?
|
| Adult | 4 | 2024 | 31282 | 0.100 |
Why?
|
| Diagnosis, Differential | 2 | 2017 | 1882 | 0.090 |
Why?
|
| Anti-Bacterial Agents | 1 | 2025 | 2596 | 0.090 |
Why?
|
| DNA Mutational Analysis | 1 | 2014 | 775 | 0.090 |
Why?
|
| Membrane Glycoproteins | 1 | 2014 | 405 | 0.090 |
Why?
|
| Interferon-gamma | 1 | 2014 | 544 | 0.090 |
Why?
|
| Combined Modality Therapy | 1 | 2014 | 1216 | 0.080 |
Why?
|
| Immunosuppressive Agents | 1 | 2014 | 663 | 0.080 |
Why?
|
| Antibodies, Viral | 1 | 2016 | 1176 | 0.080 |
Why?
|
| Prevalence | 1 | 2016 | 2701 | 0.070 |
Why?
|
| Disease Progression | 1 | 2014 | 2200 | 0.070 |
Why?
|
| Child | 2 | 2025 | 26341 | 0.070 |
Why?
|
| Retrospective Studies | 2 | 2025 | 17753 | 0.070 |
Why?
|
| Disease Models, Animal | 1 | 2018 | 4697 | 0.070 |
Why?
|
| World Health Organization | 1 | 2025 | 118 | 0.060 |
Why?
|
| Hematocrit | 1 | 2025 | 104 | 0.060 |
Why?
|
| Feasibility Studies | 1 | 2026 | 824 | 0.050 |
Why?
|
| Bronchopulmonary Dysplasia | 1 | 2025 | 222 | 0.050 |
Why?
|
| Ultrasonography | 1 | 2026 | 943 | 0.040 |
Why?
|
| Sex Factors | 1 | 2025 | 1356 | 0.040 |
Why?
|
| Mice | 1 | 2018 | 18301 | 0.040 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2024 | 248 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2025 | 3763 | 0.040 |
Why?
|
| Risk Factors | 2 | 2025 | 11074 | 0.040 |
Why?
|
| Oxygen | 1 | 2023 | 548 | 0.040 |
Why?
|
| Cerebrovascular Circulation | 1 | 2023 | 487 | 0.040 |
Why?
|
| Length of Stay | 1 | 2025 | 1421 | 0.040 |
Why?
|
| Reproducibility of Results | 1 | 2026 | 2904 | 0.040 |
Why?
|
| Cytokines | 1 | 2025 | 1339 | 0.040 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 1 | 2019 | 48 | 0.040 |
Why?
|
| Symptom Assessment | 1 | 2019 | 110 | 0.030 |
Why?
|
| Subarachnoid Space | 1 | 2018 | 23 | 0.030 |
Why?
|
| Evoked Potentials, Visual | 1 | 2018 | 29 | 0.030 |
Why?
|
| Colombia | 1 | 2018 | 51 | 0.030 |
Why?
|
| Evoked Potentials, Auditory | 1 | 2018 | 45 | 0.030 |
Why?
|
| Blueberry Plants | 1 | 2017 | 6 | 0.030 |
Why?
|
| Cerebrospinal Fluid | 1 | 2018 | 99 | 0.030 |
Why?
|
| Animals | 1 | 2018 | 33912 | 0.030 |
Why?
|
| Calcinosis | 1 | 2018 | 180 | 0.030 |
Why?
|
| Syndrome | 1 | 2019 | 1155 | 0.030 |
Why?
|
| Biomarkers | 1 | 2025 | 3385 | 0.030 |
Why?
|
| Immunohistochemistry | 1 | 2019 | 1591 | 0.030 |
Why?
|
| Diagnostic Imaging | 1 | 2018 | 305 | 0.030 |
Why?
|
| Hydrocephalus | 1 | 2018 | 245 | 0.030 |
Why?
|
| Uterus | 1 | 2019 | 541 | 0.030 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 554 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 5196 | 0.030 |
Why?
|
| Curriculum | 1 | 2020 | 798 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2018 | 1490 | 0.020 |
Why?
|
| Ultrasonography, Prenatal | 1 | 2019 | 986 | 0.020 |
Why?
|
| Clinical Competence | 1 | 2020 | 1050 | 0.020 |
Why?
|
| Surveys and Questionnaires | 1 | 2020 | 4066 | 0.020 |
Why?
|
| Phenotype | 1 | 2019 | 4497 | 0.020 |
Why?
|
| Cohort Studies | 1 | 2018 | 5063 | 0.020 |
Why?
|
| Adolescent | 1 | 2018 | 20987 | 0.010 |
Why?
|